These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 23300239)
1. Fecal shedding of Shiga toxin-producing Escherichia coli: what should be done to prevent secondary cases? Mody RK; Griffin PM Clin Infect Dis; 2013 Apr; 56(8):1141-4. PubMed ID: 23300239 [No Abstract] [Full Text] [Related]
2. Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study. Vonberg RP; Höhle M; Aepfelbacher M; Bange FC; Belmar Campos C; Claussen K; Christner M; Cramer JP; Haller H; Hornef M; Fickenscher H; Fraedrich K; Knobloch JK; Kühbacher T; Manns MP; Nitschke M; Peters G; Pulz M; Rohde H; Roseland RT; Sayk F; Schaumburg F; Schöcklmann HO; Schubert S; Solbach W; Karch H; Suerbaum S Clin Infect Dis; 2013 Apr; 56(8):1132-40. PubMed ID: 23300241 [TBL] [Abstract][Full Text] [Related]
3. Hemolytic uremic syndrome due to shiga-like toxin producing Escherichia coli 048:H21 in South Australia. Goldwater PN; Bettelheim KA Emerg Infect Dis; 1995; 1(4):132-3. PubMed ID: 8903183 [No Abstract] [Full Text] [Related]
4. Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. Frank C; Werber D; Cramer JP; Askar M; Faber M; an der Heiden M; Bernard H; Fruth A; Prager R; Spode A; Wadl M; Zoufaly A; Jordan S; Kemper MJ; Follin P; Müller L; King LA; Rosner B; Buchholz U; Stark K; Krause G; N Engl J Med; 2011 Nov; 365(19):1771-80. PubMed ID: 21696328 [TBL] [Abstract][Full Text] [Related]
6. Highlights from the clinical symposium on Shiga toxin-producing Escherichia coli / haemolytic uremic syndrome, Berlin, September 2011. Jansen A Euro Surveill; 2011 Sep; 16(39):. PubMed ID: 21968425 [No Abstract] [Full Text] [Related]
7. Early findings in outbreak of haemolytic uraemic syndrome among young children caused by Shiga toxin-producing Escherichia coli, Romania, January to February 2016. Peron E; Zaharia A; Zota LC; Severi E; Mårdh O; Usein C; Bălgrădean M; Espinosa L; Jansa J; Scavia G; Rafila A; Serban A; Pistol A Euro Surveill; 2016; 21(11):30170. PubMed ID: 27020906 [TBL] [Abstract][Full Text] [Related]
8. [Epidemic of EHEC (Escherichia coli O104:H4) in Europe in 2011--clinical and therapeutic problems]. Simon K; Janocha J Przegl Epidemiol; 2012; 66(1):73-7. PubMed ID: 22708302 [TBL] [Abstract][Full Text] [Related]
9. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli. Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728 [TBL] [Abstract][Full Text] [Related]
11. The German 2011 epidemic of Shiga toxin-producing E. Coli--the nephrological view. German EHEC-HUS Registry Nephrol Dial Transplant; 2011 Sep; 26(9):2723-6. PubMed ID: 21852273 [No Abstract] [Full Text] [Related]
12. [Escherichia coli associated hemolytic and uremic syndrome: what lessons can be learned after the European epidemic of 2011?]. Lemaignen A; Ridel C; Hertig A; Rondeau E Nephrol Ther; 2013 Jun; 9(3):129-36. PubMed ID: 23266201 [TBL] [Abstract][Full Text] [Related]
13. "HUS diary" of a German nephrologist during the current EHEC outbreak in Europe. Harendza S Kidney Int; 2011 Oct; 80(7):687-9. PubMed ID: 21734639 [No Abstract] [Full Text] [Related]
14. [Enterohemorrhagic Escherichia coli and its infection: from 1977 to 1995]. Takede Y Nihon Rinsho; 1997 Mar; 55(3):635-40. PubMed ID: 9086772 [TBL] [Abstract][Full Text] [Related]
15. A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections. Wu CJ; Hsueh PR; Ko WC J Microbiol Immunol Infect; 2011 Oct; 44(5):390-3. PubMed ID: 21862425 [TBL] [Abstract][Full Text] [Related]
16. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. Nitschke M; Sayk F; Härtel C; Roseland RT; Hauswaldt S; Steinhoff J; Fellermann K; Derad I; Wellhöner P; Büning J; Tiemer B; Katalinic A; Rupp J; Lehnert H; Solbach W; Knobloch JK JAMA; 2012 Mar; 307(10):1046-52. PubMed ID: 22416100 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of a recombinant Intimin, EspB and Shiga toxin 2B vaccine in calves experimentally challenged with Escherichia coli O157:H7. Martorelli L; Garimano N; Fiorentino GA; Vilte DA; Garbaccio SG; Barth SA; Menge C; Ibarra C; Palermo MS; Cataldi A Vaccine; 2018 Jun; 36(27):3949-3959. PubMed ID: 29807709 [TBL] [Abstract][Full Text] [Related]
18. Shopper cards data and storage practices for the investigation of an outbreak of Shiga-toxin producing Escherichia coli O157 infections. Barret AS; Charron M; Mariani-Kurkdjian P; Gouali M; Loukiadis E; Poignet-Leroux B; Godron A; Gault G; Faure M; Mailles A; Med Mal Infect; 2013 Sep; 43(9):368-73. PubMed ID: 23910937 [TBL] [Abstract][Full Text] [Related]
19. Rapid and sensitive detection of Shiga toxin-producing Escherichia coli directly from stool samples by real-time PCR in comparison to culture, enzyme immunoassay and Vero cell cytotoxicity assay. Gerritzen A; Wittke JW; Wolff D Clin Lab; 2011; 57(11-12):993-8. PubMed ID: 22239032 [TBL] [Abstract][Full Text] [Related]